Robert D Noyce, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Dr. Larry Irwin Lutwick, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Raed Jabr, Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Fnu Shweta, MBBS Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Katrina Victoria, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 900 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-717-4121 |
News Archive
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that that it has entered into a $40 million royalty financing agreement with Cowen Healthcare Royalty Partners, L.P. ("Cowen Royalty").
University of South Australia researchers are appealing for greater support mechanisms to help women diagnosed with gestational diabetes return to or maintain a healthy weight post pregnancy.
Imagine a close friend tells you she has dementia. Would you avoid her for fear of being embarrassed by what she might say or do? According to a recent poll by Alzheimer's Disease International, 40 per cent of people with dementia reported they had been avoided or treated differently after diagnosis. It's no surprise, then, that one in four respondents cited stigma as a reason to conceal their diagnosis.
A new study by researchers at the University of Strathclyde, published as a preprint on the medRxiv* server, examined changes in 24-hour movement behaviors across three designated period blocks: from 1) pre-lockdown (T1) to the 1st UK national lockdown (T2); and 2) first UK national lockdown to initial easing of lockdown (T3).
Maxygen, Inc., a biopharmaceutical company focused on the development of improved versions of protein drugs, today announced that it has extended the expiration date for its modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock, which was commenced on November 13, 2009.
› Verified 3 days ago